BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Phaeton Research Appoints New Operations Director


10/19/2005 5:10:39 PM

Drug delivery problem-solver Phaeton Research (www.phaetonresearch.com), based in Nottingham, UK, has announced the appointment of Dr Shohré Nabahi as its new Operations Director. The company, re-launched during the Summer of 2003, is part of Prophilian Group, which also includes niche Phase I/IIa CRO Pharmaceutical Profiles (www.pharmprofiles.com), specialises in developing innovative solutions for difficult molecules via customised advanced drug delivery technologies. Shohré will be responsible for providing direction to Phaeton’s Pharmaceutical R&D group which is involved in developing products from concept to utilisation in Phase I clinical studies. She will also be promoting the involvement of Phaeton Research in developing future drug delivery technologies which will be appropriate for a range of global pharmaceutical and biotechnology companies with 'problem' molecules and would secure the company valuable Intellectual Property.

Read at WebitPR

WebitPR
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES